A detailed history of Great West Life Assurance CO transactions in Ardelyx, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 27,680 shares of ARDX stock, worth $135,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,680
Previous 63,363 56.32%
Holding current value
$135,355
Previous $469,000 59.28%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.28 - $7.57 $188,406 - $270,120
-35,683 Reduced 56.32%
27,680 $191,000
Q2 2024

Aug 12, 2024

BUY
$5.89 - $9.31 $210,172 - $332,208
35,683 Added 128.91%
63,363 $469,000
Q3 2023

Nov 14, 2023

BUY
$3.3 - $4.83 $61,089 - $89,412
18,512 Added 201.92%
27,680 $113,000
Q1 2023

May 12, 2023

BUY
$2.68 - $4.79 $24,570 - $43,914
9,168 New
9,168 $44,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $3,940 - $7,789
-4,582 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$5.37 - $8.11 $24,605 - $37,160
4,582 New
4,582 $32,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $756M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.